zombywolf: What I don't get is what is going on
Sequential Q4 vs. Q3 revenue (not YTD info)
Product: $294k vs $488k
Licensing: $39k vs $108k
Equip Lease: $249K vs $177k
Total: $582k vs $784k
Product $ is declining, I think because of the drop in surface cleaning "theater". However, hospital still need this stuff. Just a question of whether they will prioritize and select PCTL. And we have to see about O&G
Licensing, looks like they were over-estimating interim qtr numbers and when they true-up at year end discovered, oops
Equip leasing, the only bright spot. This is good re-occurring revenue, however this pretty much makes the company a financing operation. And based on my research, they do not have much leverage in this area. RB capital may help, but based on Q4 financing activity, there is still a long ways to go. ~ Z